English | Español
Patient Daily | Feb 4, 2026

Cellares raises $257M for expansion of automated cell therapy manufacturing
Patient Daily | Feb 4, 2026

Roche reports positive results in obesity drug trial; Moderna halts vaccine studies
Patient Daily | Feb 4, 2026

FDA holds up REGENXBIO's Hunter syndrome program; Denali may move ahead
Patient Daily | Feb 4, 2026

Cardiff Oncology faces executive departures and mixed phase II trial results
Patient Daily | Feb 4, 2026

FDA approves new frontline use for J&J's Darzalex Faspro in multiple myeloma
Patient Daily | Feb 4, 2026

Baylor College team develops method for sustained laboratory growth of human norovirus
Patient Daily | Feb 4, 2026

Study finds Americans expect families—especially spouses—to lead eldercare responsibilities
Patient Daily | Feb 4, 2026

Penn Medicine launches 24/7 virtual service replacing traditional on-call hours

Trending
+ Pharmaceuticals
Patient Daily | Apr 5, 2026

Amplifon announces $2 billion acquisition of GN Hearing in strategic shift
Patient Daily | Apr 7, 2026

ProPublica examines impact of RFK Jr.'s vaccine policies on childhood disease risks
+ Pharmaceuticals
Patient Daily | Apr 1, 2026

Biopharma mergers and acquisitions reach $46.8 billion in first quarter of 2026
+ Regulatory
Patient Daily | Apr 8, 2026

Columbia University Professor Masia on 340B: '340B has become a drug mark-up program. Hospitals buy drugs at low cost and sell them high'